0001012975-24-000374.txt : 20240830 0001012975-24-000374.hdr.sgml : 20240830 20240830161003 ACCESSION NUMBER: 0001012975-24-000374 CONFORMED SUBMISSION TYPE: N-PX PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240830 EFFECTIVENESS DATE: 20240830 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Euclidean Capital LLC CENTRAL INDEX KEY: 0001825034 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: N-PX SEC ACT: 1934 Act SEC FILE NUMBER: 028-20777 FILM NUMBER: 241270103 BUSINESS ADDRESS: STREET 1: 160 FIFTH AVE, 9TH FL CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 212-537-0335 MAIL ADDRESS: STREET 1: 160 FIFTH AVE, 9TH FL CITY: NEW YORK STATE: NY ZIP: 10010 N-PX 1 primary_doc.xml N-PX IM LIVE 0001825034 XXXXXXXX false false 06/30/2024 YEAR 2024 Euclidean Capital LLC 212-537-0310

160 FIFTH AVE, 9TH FL NEW YORK NY 10010

INSTITUTIONAL MANAGER VOTING REPORT N 028-20777 54930088UJIT3V1XWZ07 N 0 Euclidean Capital LLC Joseph Cosmai Joseph Cosmai Manager 08/30/2024 PROXY VOTING RECORD 2 euclidean-voting-table3.xml PROXY VOTING RECORD ALECTOR INC 014442107 US0144421072 BBG00NGHXD36 06/12/2024 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES 0 0 23ANDME HOLDING CO 90138Q108 US90138Q1085 BBG00XV5CYH5 09/06/2023 A non-binding, advisory vote on the Fiscal 2023 compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 0 0 PMV PHARMACEUTICALS INC 69353Y103 US69353Y1038 BBG007NM47G3 06/06/2024 Approval, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 0 0 QUALIGEN THERAPEUTICS INC 74754R202 US74754R2022 BBG008D03RS4 07/13/2023 To approve on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 17482.4 0 FOR 17482.4 FOR